Fourpath Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-165
Closed -$26.9K 338
2024
Q3
$26.9K Buy
+165
New +$24.4K 0.01% 400
2023
Q2
Sell
-3,007
Closed -$476K 107
2023
Q1
$476K Sell
3,007
-1,735
-37% -$260K 0.33% 76
2022
Q4
$665K Sell
4,742
-24
-0.5% -$3.41K 0.48% 55
2022
Q3
$612K Hold
4,766
0.42% 56
2022
Q2
$672K Buy
4,766
+2,138
+81% +$305K 0.42% 58
2022
Q1
$365K Buy
+2,628
New +$403K 0.15% 113

Other funds holding CLX

Fourpath Capital Management's CLX Position: Q4 2024 in Review

Fourpath Capital Management sold out of Clorox (CLX) in Q4 2024, closing a stake of 165 shares — an estimated $26.9K sold.

Fourpath Capital Management first reported a position in CLX in Q1 2022 and held it in 6 quarters. The position peaked at $672K in Q2 2022. 1,222 funds tracked by Wall St. Rank hold CLX as of Q4 2024.

  • Fourpath Capital Management reported no remaining Clorox position as of Q4 2024 after selling out during the quarter.
  • Fourpath Capital Management sold 165 Clorox shares in Q4 2024, an estimated $26.9K.
  • Fourpath Capital Management first reported a position in Clorox in Q1 2022 and held it in 6 quarters.
  • Fourpath Capital Management's Clorox position peaked at $672K in Q2 2022.
  • 1,222 funds tracked by Wall St. Rank held Clorox as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.